Cargando…
Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
BACKGROUND: This study was designed to investigate whether COVID-19 patients with recently received immunotherapy or other anti-cancer treatments had more severe symptoms and higher mortality. METHODS: A literature search was performed using the electronic platforms to obtain relevant research studi...
Autores principales: | Wang, Bolin, Huang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710316/ https://www.ncbi.nlm.nih.gov/pubmed/33294299 http://dx.doi.org/10.1080/2162402X.2020.1824646 |
Ejemplares similares
-
1677MO COVID-19 mortality in hospitalized cancer patients is not significantly affected by chemotherapy or other anti-cancer treatments
por: Lee, L., et al.
Publicado: (2020) -
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis
por: Liu, Yanqiong, et al.
Publicado: (2014) -
Does hypothyroidism increase the risk of breast cancer: evidence from a meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020) -
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020) -
Hypogammaglobulinemia and Risk of Exacerbation and Mortality in Patients with COPD
por: Holm, Are M, et al.
Publicado: (2020)